Table 3.
Minimum inhibitory concentration of celecoxib against clinical isolates of S. aureus strains.
| Strain type | Strain ID | Source | Phenotypic properties | Celecoxib (μg/ml) |
|---|---|---|---|---|
| Methicillin resistant | USA100 | U. S. (OH) | Resistant to ciprofloxacin, clindamycin, | 32 |
| S. aureus (MRSA) | erythromycin | |||
| USA200 | U. S. (NC) | Resistant to clindamycin, methicillin | 32 | |
| erythromycin, gentamicin, | ||||
| USA300 | U. S. (MS) | Resistant to erythromycin, methicillin, tetracycline | 32 | |
| USA400 | U. S. (ND) | Resistant to methicillin, tetracycline | 16 | |
| USA500 | U. S. (CT) | Resistant to ciprofloxacin, clindamycin, | 32 | |
| erythromycin, gentamicin, | ||||
| methicillin, tetracycline, trimethoprim | ||||
| USA700 | U. S. (LA) | Resistant to erythromycin, methicillin | 32 | |
| USA800 | U. S. (WA) | Resistant to methicillin | 32 | |
| USA1000 | U. S. (VT) | Resistant to erythromycin, methicillin | 32 | |
| USA1100 | U. S. (AL) | Resistant to methicillin | 32 | |
| NRS194 | U. S. (ND) | Resistant to methicillin | 32 | |
| NRS108 | France | Resistant to gentamicin | 32 | |
| NRS119 | U. S. (MA) | Resistant to linezolid | 16 | |
| ATCC 43300 | U. S. (KS) | Resistant to methicillin | 32 | |
| ATCC BAA-44 | Lisbon, Portugal | Multidrug-resistant strain | 32 | |
| NRS70 | Japan | Resistant to erythromycin, clindamycin, spectinomycin | 32 | |
| NRS71 | UK | Resistant to tetracycline, methicillin | 32 | |
| NRS100 | U. S. | Resistant to tetracycline, methicillin | 32 | |
| NRS107 | U. S. | Resistant to methicillin, mupirocin | 32 | |
| Vancomycin-intermediate | NRS1 | Japan | Resistant to aminoglycosides and | 32 |
| S. aureus (VISA) | tetracycline; glycopeptide- intermediate S. aureus | |||
| NRS19 | U. S. (IL) | Glycopeptide-intermediate S. aureus | 32 | |
| NRS37 | France | Glycopeptide-intermediate S. aureus | 32 | |
| Vancomycin-resistant | VRS1 | U. S. | Resistant to vancomycin | 128 |
| S. aureus (VRSA) | VRS2 | U. S. | Resistant to vancomycin, erythromycin, spectinomycin | 128 |
| VRS3a | U. S. | Resistant to vancomycin | 32 | |
| VRS3b | U. S. | Resistant to vancomycin | 32 | |
| VRS4 | U. S. | Resistant to vancomycin, erythromycin, spectinomycin | 128 | |
| VRS5 | U. S. | Resistant to vancomycin | 16 | |
| VRS6 | U. S. | Resistant to vancomycin | 16 | |
| VRS7 | U. S. | Resistant to vancomycin, β-lactams | 128 | |
| VRS8 | U. S. | Resistant to vancomycin | 32 | |
| VRS9 | U. S. | Resistant to vancomycin | 64 | |
| VRS11a | U. S. | Resistant to vancomycin | 32 | |
| VRS11b | U. S. | Resistant to vancomycin | 32 | |
| VRS12 | U. S. | Resistant to vancomycin | 32 | |
| VRS13 | U. S. | Resistant to vancomycin | 32 |